Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA002196 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA002196, RRID:AB_1079107
- Product name
- Anti-IGFBP7
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human IGFBP7, Gene description: insulin-like growth factor binding protein 7, Alternative Gene Names: FSTL2, IGFBP-7, MAC25, PSF, Validated applications: IHC, Uniprot ID: Q16270, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.05 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
Oncogenic Pathways and Loss of the Rab11 GTPase Synergize To Alter Metabolism in Drosophila
IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome
Pilot study identifying myosin heavy chain 7, desmin, insulin‐like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure
Jackstadt R, van Hooff S, Leach J, Cortes-Lavaud X, Lohuis J, Ridgway R, Wouters V, Roper J, Kendall T, Roxburgh C, Horgan P, Nixon C, Nourse C, Gunzer M, Clark W, Hedley A, Yilmaz O, Rashid M, Bailey P, Biankin A, Campbell A, Adams D, Barry S, Steele C, Medema J, Sansom O
Cancer Cell 2019;36(3):319-336.e7
Cancer Cell 2019;36(3):319-336.e7
Oncogenic Pathways and Loss of the Rab11 GTPase Synergize To Alter Metabolism in Drosophila
Nie Y, Yu S, Li Q, Nirala N, Amcheslavsky A, Edwards Y, Shum P, Jiang Z, Wang W, Zhang B, Gao N, Ip Y
Genetics 2019;212(4):1227-1239
Genetics 2019;212(4):1227-1239
IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer
Wu S, Chang T, Tsai M, Liu Y, Hsu C, Chang Y, Yu C, Shih J
Cancers 2019;11(1):36
Cancers 2019;11(1):36
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Tauriello D, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, Sevillano M, Ibiza S, Cañellas A, Hernando-Momblona X, Byrom D, Matarin J, Calon A, Rivas E, Nebreda A, Riera A, Attolini C, Batlle E
Nature 2018;554(7693):538-543
Nature 2018;554(7693):538-543
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, Sevillano M, Palomo-Ponce S, Tauriello D, Byrom D, Cortina C, Morral C, Barceló C, Tosi S, Riera A, Attolini C, Rossell D, Sancho E, Batlle E
Nature Genetics 2015;47(4):320-329
Nature Genetics 2015;47(4):320-329
Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome
Gambaro K, Quinn M, Cáceres-Gorriti K, Shapiro R, Provencher D, Rahimi K, Mes-Masson A, Tonin P
BMC Cancer 2015;15(1)
BMC Cancer 2015;15(1)
Pilot study identifying myosin heavy chain 7, desmin, insulin‐like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure
Chugh S, Ouzounian M, Lu Z, Mohamed S, Li W, Bousette N, Liu P, Gramolini A
PROTEOMICS 2013;13(15):2324-2334
PROTEOMICS 2013;13(15):2324-2334
No comments: Submit comment
No validations: Submit validation data